BIOMARKERS OF TARGET MODULATION, EFFICACY, DIAGNOSIS AND/OR PROGNOSIS FOR RAF INHIBITORS

Methods of utilizing biomarkers to identify patients for treatment or to monitor response to treatment are taught herein. Alterations in levels of gene expression of the biomarkers, particularly in response to Raf kinase inhibition, are measured and identifications or adjustments may be made accordi...

Full description

Saved in:
Bibliographic Details
Main Authors AARDELEN KIM, STUART DARRIN, AZIZ NATASHA, HEISE CARLA, MOLER EDWARD
Format Patent
LanguageEnglish
Published 07.01.2010
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

Abstract Methods of utilizing biomarkers to identify patients for treatment or to monitor response to treatment are taught herein. Alterations in levels of gene expression of the biomarkers, particularly in response to Raf kinase inhibition, are measured and identifications or adjustments may be made accordingly.
AbstractList Methods of utilizing biomarkers to identify patients for treatment or to monitor response to treatment are taught herein. Alterations in levels of gene expression of the biomarkers, particularly in response to Raf kinase inhibition, are measured and identifications or adjustments may be made accordingly.
Author AZIZ NATASHA
AARDELEN KIM
STUART DARRIN
MOLER EDWARD
HEISE CARLA
Author_xml – fullname: AARDELEN KIM
– fullname: STUART DARRIN
– fullname: AZIZ NATASHA
– fullname: HEISE CARLA
– fullname: MOLER EDWARD
BookMark eNqNiksOgjAUALvQhb87vMQtxgJ6gAe08KL0mbYkuiLE1JUBErx_dMEBXE1mMmux6Ic-rMQ9I67RXpR1wBo82lJ5qLloruiJTQRKa8oxf0RQEJaGHTlAUxzZws3yHPTPLGogU1FGnq3biuWre09hN3Mj9lr5vDqEcWjDNHbP0IdP27hExlLKU3JOMU7_u77jzTOv
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2010004253A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2010004253A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:53:57 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2010004253A13
Notes Application Number: US20070441888
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100107&DB=EPODOC&CC=US&NR=2010004253A1
ParticipantIDs epo_espacenet_US2010004253A1
PublicationCentury 2000
PublicationDate 20100107
PublicationDateYYYYMMDD 2010-01-07
PublicationDate_xml – month: 01
  year: 2010
  text: 20100107
  day: 07
PublicationDecade 2010
PublicationYear 2010
RelatedCompanies NOVARTIS AG
RelatedCompanies_xml – name: NOVARTIS AG
Score 2.7555141
Snippet Methods of utilizing biomarkers to identify patients for treatment or to monitor response to treatment are taught herein. Alterations in levels of gene...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Title BIOMARKERS OF TARGET MODULATION, EFFICACY, DIAGNOSIS AND/OR PROGNOSIS FOR RAF INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100107&DB=EPODOC&locale=&CC=US&NR=2010004253A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwEA5jivqmU_HHlIDSp5XNtVu2hyJp0m5V24y0lfk02rWCIN1wFf99r12ne9pbSOBIjny5-5LcHUL3GoF9kxBNjdM4UvWoKPPSTTpqBL7DIIlJpL0Xwcmu1x-H-tO0N62hz00sTJkn9KdMjgiImgPe8_K8Xv5fYvHyb-WqHX9A1-LRDgyuVOy4SCjUIQo3DWsiuGAKY0boK55cjxUbVKPAlfbAkSYFHqxXs4hLWW4bFfsY7U9AXpafoFqaNdAh29Rea6ADt3ryhmaFvtUpmpqOcKl8tqSPhY0DKkdWgF3Bw5fypqmFwet0GGVvLcwdOvKE7_iYerwtJJ5IUXUA78OS2tjxxo7pBEL6Z-jOtgI2VmGKsz-NzEJ_ez3aOapniyy9QLgL1oWkoOLBvKenejRMgIH2hwnwFLD9Sf8SNXdJuto9fI2O1o_nD2qHNFE9__pOb8Am5_FtqcpfQzGHTQ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbosYP1CaaPbGAbDB4IGafrMJW0m0Gn8jGZmJiBpEZ_31vYyhPvDVtcmkv_fXu1_buAB4lBfdNrEhilEShKId5mZdO3BZD9B36caSE0nsenOy4PTuQX2bdWQU-t7EwRZ7QnyI5IiJqgXjPivN69X-JZRR_K9et6AO7ls-WPzSEkh3nCYXaimBoQ3PKDKYLuj4MPMHlm7F8g0oqcqUDdLKVHA_mq5bHpax2jYp1AodTlJdmp1BJ0jrU9G3ttTocOeWTNzZL9K3PYKZR5qh8bHKPMIv4Kh-ZPnGYEUyKm6YmQa-T6qr-1iQGVUcu86hHVNdoMU6mnJUdyPsIVy1CXZtq1GfcO4cHy_R1W8Qpzv80Mg-83fVIF1BNl2lyCaSD1kVJUMX9RVdO5HAQIwPtDWLkKWj7494VNPZJut4_fA8123cm8wl1xzdwvHlIfxLbSgOq2dd3cov2OYvuCrX-AsiUikA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=BIOMARKERS+OF+TARGET+MODULATION%2C+EFFICACY%2C+DIAGNOSIS+AND%2FOR+PROGNOSIS+FOR+RAF+INHIBITORS&rft.inventor=AARDELEN+KIM&rft.inventor=STUART+DARRIN&rft.inventor=AZIZ+NATASHA&rft.inventor=HEISE+CARLA&rft.inventor=MOLER+EDWARD&rft.date=2010-01-07&rft.externalDBID=A1&rft.externalDocID=US2010004253A1